This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Medical Equipment Reimbursement Market

Market Insights on Medical Equipment Reimbursement covering sales outlook, demand forecast & up-to-date key trends

Medical Equipment Reimbursement Market by Payer Type, Healthcare Setting & Region - Forecast 2022 - 2032

Medical Equipment Reimbursement Market Outlook (2022-2032)

[250 Pages Report] Newly released Medical Equipment Reimbursement Market analysis report by Future Market Insights shows that global sales of the Medical Equipment Reimbursement Market in 2021 were held at US$ 414.1 Mn. With 12.9%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.

Private is expected to be the highest revenue-generating Payer, projected to grow at a CAGR of over 12.9% during 2022 – 2032.

Attributes

Details

Medical Equipment Reimbursement Market CAGR (2022-2032)

12.9%

Medical Equipment Reimbursement Market Size (2022)

US$ 464.2 Mn

Medical Equipment Reimbursement Market Size (2032)

US$ 1.5 Bn

Customize this Report

Let us know your requirement to get
100% FREE customization

Revenue Of Medical Equipment Reimbursement Market From 2017 To 2021 Compared To Demand Outlook For 2022 To 2032

As per the Medical Equipment Reimbursement Market research by Future Market Insights - market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Medical Equipment Reimbursement Market increased at around 11.1% CAGR.

Medical device reimbursements are made to a healthcare provider by third parties, such as private or public health insurers, for expenses incurred while using the medical equipment. The market growth is being driven by a growing reliance on reimbursement, the surge in the prevalence of chronic diseases, and an increase in preventative care.

The focus on early diagnosis and preventative treatment may lead to increased activity in the diagnostic equipment market, resulting in increased reimbursement share. For example, in developed economies, breast cancer screening, a fundamental paradigm change toward rewarding early diagnosis through payment has been observed.

With the rising need for healthcare equipment, remuneration services are likely to present a plethora of opportunities for the healthcare industry to take advantage of. In addition, the market is being fuelled by an increase in the number of people seeking insurance and the consolidation of the healthcare system.

What Factors Are Propelling Medical Equipment Reimbursement Demand?

Over the projected period, the global Medical Equipment Reimbursement market is expected to develop due to an increase in the number of chronic diseases and their preventive care. Increased attention to early diagnosis and preventative treatment may lead to increased activity in the diagnostic device business, resulting in a higher remuneration share.

For example, in developed countries, such as breast cancer screening, a major paradigm change toward promoting early diagnosis through remuneration has been observed.

An increasing patient population, more awareness of insurance policies, and rising healthcare costs are all factors that are boosting the market expansion for medical device reimbursement.

The Medical Equipment Reimbursement market is on the surge due to the growing occurrence of prolonged diseases such as diabetes, cardiovascular diseases (CVD), and others. Diabetes affects roughly 422 Mn people globally, a large proportion of whom are from low-income countries.

Furthermore, diabetes kills another 1.6 Mn people each year, according to the World Health Organization (WHO). Additionally, during the forecast period 2022-2032, an increase in healthcare prices is expected to boost the Medical Equipment Reimbursement market's growth.

Aditya Birla Health Insurance Company Ltd., for example, launched a campaign named "ABHI Karo" to raise public awareness about health insurance. The surging healthcare cost, coupled with supportive government policies, has been adding to the number of people who choose payer services, thus propelling the demand for medical device reimbursement from 2022 to 2032.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Industries Pulled The Growth Trigger In Medical Equipment Reimbursement Market?

Reimbursement of medical devices is gaining popularity in the insurance industry. In the United States alone, the healthcare payment system is intricate, and reimbursement details vary from one country to the next. It would be a good idea to become familiar with your reimbursement possibilities ahead of time.

In time, the health system will demand more and more devices, which will present a steep rise in the reimbursement industry. Along with demographic developments, this will be a major factor in the requirement for medical care expenditures. Other factors contributing to the rapid development of the industry are the cost of healthcare, the ever-expanding patient population, as well as growing awareness about health insurance policies.

Private and public payer services are included in the payer services section. Due to factors such as rising demand for improved treatment and the rising prevalence of diabetes and cancer, the private segment is likely to rise at a fast pace throughout the forecast period.

The global Medical Equipment Reimbursement market has been divided into outpatient facilities, hospitals, and other healthcare settings. Due to reasons such as the increased frequency of chronic diseases and the growing older population, the hospital segment is likely to grow at a profitable rate over the forecast period.

A determination of reimbursement is made from one or the other of two sources as a payment for clothes or accessories that are worn to support or in treating a medical condition, or as a payment for a continuous time during which surgery comprising a surgical device or medical instrument was performed. Medical coding and electronic medical record (EMR) use are common in used care providers.

Region-Wise Analysis

Which Region is projected to Offer the Largest Opportunity for Medical Equipment Reimbursement Market?

North America dominated the medical device reimbursement market in 2021, accounting for 50% of total revenue, and is likely to continue to do so throughout the forecast period. Over the forecast period, rising cases of numerous severe diseases are expected to boost the market.

Furthermore, as compared to other locations in the region, the reimbursement framework is the most advanced. Committees revise the list of devices every two years to ensure that the most recent products are included in the reimbursement scheme.

The need for medical device reimbursement is projected to rise as regulatory conditions change and pressure on the healthcare business to reduce service costs grows. As a result, the market is likely to grow throughout the forecast period.

In Europe, the market is likely to be driven by an increase in the number of healthcare centers and increased demand for medical equipment. However, rising healthcare expenditure, rising chronic disease prevalence, and rising resource demand in developing countries like China, Japan, South Korea, and India are expected to drive considerable growth in the Asia Pacific throughout the projection period.

In order to streamline and establish a highly efficient healthcare management system, these countries are implementing policies similar to those used in the United States and Europe.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-Wise Analysis

Which Country Lies at the Center Stage for Medical Equipment Reimbursement Market Revenue?

The United States is expected to have the highest market share of US$ 609.1 Mn by the end of 2032 with North America being the dominant player and accounting for 50% of the total sales. The healthcare supplier community might see more demand for healthcare reimbursers and more significant comprehension of the ways it can become more expensive. Additionally, it is more likely to encourage healthcare centers.

The rise in the volume of chronic diseases is spurring demand for a range of healthcare devices. Since the advent of the coronavirus pandemic, the medical device industry has been negatively impacted, but demand for homecare medical equipment has increased. This has a positive influence on remote monitoring devices, wearable devices, home infusion equipment, and durable healthcare instruments reimbursement coverage.

Increased reimbursement for medical devices will spur technological breakthroughs by medical device manufacturers. In the long run, this will result in greater healthcare outcomes and cost-efficiency. In order to boost their profit margins, medical device companies are also spending on consulting for the drafting of appropriate reimbursement submissions for regulatory bodies.

This trend is predicted to continue, as reimbursement remains as the hurdle for medical device manufacturers to overcome in order to gain coverage and attract risk-averse investors.

Since the passage of the Affordable Care Act, the healthcare industry in North America, has shifted from a volume-based to a value-based care model, fueling the demand for reimbursement consulting.

Category-Wise Insights

Why do Private Payers stand as the Most Potential Revenue Source for Medical Equipment Reimbursement?

Revenue through the private payers category is forecasted to grow at the highest CAGR of over 12.8% during 2022-2032. The medical technology industry had the highest sales ratio of over 65% in 2021 over all other market segments. A large number of new businesses contributed to this sector's growth.

The revenue category is projected to hold its prominence in the marketplace over the long-term forecast. In addition, the reimbursement criteria presently reflect the purchase price of a product or a treatment, not the value of the technology used. Using the lower average reimbursement, advanced technology medical devices are not commonly available in public health systems.

The rising rate of public payers which serve both emerging and developed regions, combined with increased medical innovation, are exposing increasingly demanding clients in the public medical device reimbursement field.

Around 8.5 million non-urgent patients were treated in the UK by the NHS in 2017, while around 135,000 people were provided with long-term medical care. As a result, the tech industry is likely to trend up over the course of the next 5 to 10 years, as the aged population increases and chronic illnesses become more common.

Which Healthcare Setting of Medical Equipment Reimbursement is expected to Score Highest Growth in the Coming Years?

The Hospitals segment is forecasted to grow at the highest CAGR of over 14.3% during 2022-2032. The Hospitals sector holds the largest market share. In 2021, the hospital setting accounted for the largest market share of 53.5%. The segment is likely to maintain its dominance over the projected period.

Furthermore, the segment is being driven by an aging population and an increase in the prevalence of chronic diseases. The increased prevalence of chronic illnesses is driving up demand for medical device reimbursement in large-scale settings such as hospitals. Over the forecast period, the outpatient facilities category is expected to increase at a fast pace of 11.8%.

What was the impact of Covid-19 on the Medical Equipment Reimbursement Market?

COVID-19 resulted in an increase in market demand for home-based care services, which is expected to have a beneficial impact on reimbursement coverage for remote monitoring, durable medical devices, and home infusion devices. During the COVID-19 pandemic, the National Association for Home Care and Hospice, as well as the ALS Association, have asked CMS for a 1,135 blanket waiver, which would cover all infusion therapy.

Competitive Analysis

Among the leading players in the global Medical Equipment Reimbursement market are UnitedHealth Group, Aetna, Cigna, Humana, and Allianz. To streamline and establish an effective healthcare system, these companies are applying policies that are already in place in wealthy countries.

Medical Equipment Reimbursement Market Report Scope

Attribute

Details

Forecast Period

2022-2032

Historical Data Available for

2017-2021

Market Analysis

US$ Bn for Value

Key Regions Covered

North America, Europe, Latin America, APAC, Middle East & Africa

Key Countries Covered

United States, Canada, Brazil, Mexico, Germany, U.K., France, Spain, Italy, Russia, China, South Korea, Japan, India, Australia

Key Market Segments Covered

Payer, Healthcare Setting, Region

Key Companies Profiled

Pricing

Available upon Request

Market Segments Covered In Medical Equipment Reimbursement Market Analysis

By Payer Type:

  • Public
  • Private

By Healthcare Setting:

  • Hospitals
  • Outpatient Facilities
  • Other Healthcare Settings

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • Middle East and Africa

Frequently Asked Questions

The global Medical Equipment Reimbursement market is worth more than US$ 414.1 Mn at present.

The value of Medical Devices are projected to increase at a CAGR of around 12.9% during 2022 – 2032.

The value of the Medical Equipment Reimbursement Market increased at a CAGR of around 11.1% during 2017 – 2021.

Over time, a growing aging population and rising healthcare costs will almost certainly increase. An increasing patient population, surge in awareness about insurance policies, and rising healthcare costs are boosting the market expansion for medical device reimbursement.

The market for Medical Equipment Reimbursement Market in the US is projected to expand at a CAGR of around 12% during 2022 – 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Payer

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Payer, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Payer, 2022-2032

        5.3.1. Public Payers

        5.3.2. Private Payers

    5.4. Y-o-Y Growth Trend Analysis By Payer, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Payer, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Healthcare Setting

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Healthcare Setting, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Healthcare Setting, 2022-2032

        6.3.1. Hospitals

        6.3.2. Outpatient Facilities

        6.3.3. Other Healthcare Settings

    6.4. Y-o-Y Growth Trend Analysis By Healthcare Setting, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Healthcare Setting, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Payer

        8.2.3. By Healthcare Setting

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Payer

        8.3.3. By Healthcare Setting

    8.4. Key Takeaways

9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Payer

        9.2.3. By Healthcare Setting

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Payer

        9.3.3. By Healthcare Setting

    9.4. Key Takeaways

10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. U.K.

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Payer

        10.2.3. By Healthcare Setting

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Payer

        10.3.3. By Healthcare Setting

    10.4. Key Takeaways

11. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. India

            11.2.1.5. Rest of Asia Pacific

        11.2.2. By Payer

        11.2.3. By Healthcare Setting

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Payer

        11.3.3. By Healthcare Setting

    11.4. Key Takeaways

12. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC

            12.2.1.2. Rest of MEA

        12.2.2. By Payer

        12.2.3. By Healthcare Setting

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Payer

        12.3.3. By Healthcare Setting

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Payer

            13.1.2.2. By Healthcare Setting

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Payer

            13.2.2.2. By Healthcare Setting

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Payer

            13.3.2.2. By Healthcare Setting

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Payer

            13.4.2.2. By Healthcare Setting

    13.5. Argentina

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Payer

            13.5.2.2. By Healthcare Setting

    13.6. Germany

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Payer

            13.6.2.2. By Healthcare Setting

    13.7. Italy

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Payer

            13.7.2.2. By Healthcare Setting

    13.8. France

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Payer

            13.8.2.2. By Healthcare Setting

    13.9. U.K.

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Payer

            13.9.2.2. By Healthcare Setting

    13.10. Spain

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Payer

            13.10.2.2. By Healthcare Setting

    13.11. Russia

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Payer

            13.11.2.2. By Healthcare Setting

    13.12. BENELUX

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Payer

            13.12.2.2. By Healthcare Setting

    13.13. China

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Payer

            13.13.2.2. By Healthcare Setting

    13.14. Japan

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Payer

            13.14.2.2. By Healthcare Setting

    13.15. South Korea

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Payer

            13.15.2.2. By Healthcare Setting

    13.16. India

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Payer

            13.16.2.2. By Healthcare Setting

    13.17. GCC Countries

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Payer

            13.17.2.2. By Healthcare Setting

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Payer

        14.3.3. By Healthcare Setting

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Value (US$ Mn)ed Health Group

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segment

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

                15.1.1.5.2. Product Strategy

        15.1.2. Aetna

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segment

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

                15.1.2.5.2. Product Strategy

        15.1.3. Cigna

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segment

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

                15.1.3.5.2. Product Strategy

        15.1.4. Humana

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segment

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

                15.1.4.5.2. Product Strategy

        15.1.5. Allianz

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segment

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

                15.1.5.5.2. Product Strategy

        15.1.6. Aviva

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segment

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

                15.1.6.5.2. Product Strategy

        15.1.7. Nippon Life Insurance

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segment

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

                15.1.7.5.2. Product Strategy

        15.1.8. CVS Health

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segment

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

                15.1.8.5.2. Product Strategy

        15.1.9. Wellcare Health Plans

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segment

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

                15.1.9.5.2. Product Strategy

        15.1.10. BNP Paribas

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segment

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

                15.1.10.5.2. Product Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 02: Global Market Value (US$ Mn) Forecast by Payer, 2017-2032

Table 03: Global Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032

Table 04: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 05: North America Market Value (US$ Mn) Forecast by Payer, 2017-2032

Table 06: North America Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032

Table 07: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 08: Latin America Market Value (US$ Mn) Forecast by Payer, 2017-2032

Table 09: Latin America Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032

Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Market Value (US$ Mn) Forecast by Payer, 2017-2032

Table 12: Europe Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032

Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Payer, 2017-2032

Table 15: Asia Pacific Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032

Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: MEA Market Value (US$ Mn) Forecast by Payer, 2017-2032

Table 18: MEA Market Value (US$ Mn) Forecast by Healthcare Setting, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value (US$ Mn) by Payer, 2022-2032

Figure 02: Global Market Value (US$ Mn) by Healthcare Setting, 2022-2032

Figure 03: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 04: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 05: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 06: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 07: Global Market Value (US$ Mn) Analysis by Payer, 2017-2032

Figure 08: Global Market Value Share (%) and BPS Analysis by Payer, 2022-2032

Figure 09: Global Market Y-o-Y Growth (%) Projections by Payer, 2022-2032

Figure 10: Global Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032

Figure 11: Global Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032

Figure 12: Global Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032

Figure 13: Global Market Attractiveness by Payer, 2022-2032

Figure 14: Global Market Attractiveness by Healthcare Setting, 2022-2032

Figure 15: Global Market Attractiveness by Region, 2022-2032

Figure 16: North America Market Value (US$ Mn) by Payer, 2022-2032

Figure 17: North America Market Value (US$ Mn) by Healthcare Setting, 2022-2032

Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Market Value (US$ Mn) Analysis by Payer, 2017-2032

Figure 23: North America Market Value Share (%) and BPS Analysis by Payer, 2022-2032

Figure 24: North America Market Y-o-Y Growth (%) Projections by Payer, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032

Figure 28: North America Market Attractiveness by Payer, 2022-2032

Figure 29: North America Market Attractiveness by Healthcare Setting, 2022-2032

Figure 30: North America Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Market Value (US$ Mn) by Payer, 2022-2032

Figure 32: Latin America Market Value (US$ Mn) by Healthcare Setting, 2022-2032

Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Market Value (US$ Mn) Analysis by Payer, 2017-2032

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Payer, 2022-2032

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Payer, 2022-2032

Figure 40: Latin America Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032

Figure 43: Latin America Market Attractiveness by Payer, 2022-2032

Figure 44: Latin America Market Attractiveness by Healthcare Setting, 2022-2032

Figure 45: Latin America Market Attractiveness by Country, 2022-2032

Figure 46: Europe Market Value (US$ Mn) by Payer, 2022-2032

Figure 47: Europe Market Value (US$ Mn) by Healthcare Setting, 2022-2032

Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Market Value (US$ Mn) Analysis by Payer, 2017-2032

Figure 53: Europe Market Value Share (%) and BPS Analysis by Payer, 2022-2032

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Payer, 2022-2032

Figure 55: Europe Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032

Figure 56: Europe Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032

Figure 57: Europe Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032

Figure 58: Europe Market Attractiveness by Payer, 2022-2032

Figure 59: Europe Market Attractiveness by Healthcare Setting, 2022-2032

Figure 60: Europe Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Market Value (US$ Mn) by Payer, 2022-2032

Figure 62: Asia Pacific Market Value (US$ Mn) by Healthcare Setting, 2022-2032

Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Payer, 2017-2032

Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Payer, 2022-2032

Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Payer, 2022-2032

Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032

Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032

Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032

Figure 73: Asia Pacific Market Attractiveness by Payer, 2022-2032

Figure 74: Asia Pacific Market Attractiveness by Healthcare Setting, 2022-2032

Figure 75: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 76: MEA Market Value (US$ Mn) by Payer, 2022-2032

Figure 77: MEA Market Value (US$ Mn) by Healthcare Setting, 2022-2032

Figure 78: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Market Value (US$ Mn) Analysis by Payer, 2017-2032

Figure 83: MEA Market Value Share (%) and BPS Analysis by Payer, 2022-2032

Figure 84: MEA Market Y-o-Y Growth (%) Projections by Payer, 2022-2032

Figure 85: MEA Market Value (US$ Mn) Analysis by Healthcare Setting, 2017-2032

Figure 86: MEA Market Value Share (%) and BPS Analysis by Healthcare Setting, 2022-2032

Figure 87: MEA Market Y-o-Y Growth (%) Projections by Healthcare Setting, 2022-2032

Figure 88: MEA Market Attractiveness by Payer, 2022-2032

Figure 89: MEA Market Attractiveness by Healthcare Setting, 2022-2032

Figure 90: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Medical Equipment Reimbursement Market